Jan 06, 2025 7:00am EST Algernon Pharmaceuticals Receives Notice of Allowance from USPTO For Repirinast in Kidney Disease Patent
Jul 16, 2024 8:00am EDT Algernon Pharmaceuticals Reports Results of Study Showing 93% Cough Suppression with Ifenprodil
May 21, 2024 7:00am EDT Algernon Pharmaceuticals Engages ICP Securities Inc. for Automated Market Making Services
